acridines has been researched along with Rhabdomyosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catchpoole, DR; He, Z; Stewart, BW; Wakelin, LP; Wolf, SJ | 1 |
| Anisimov, VN; Bakhtin, IuB; Iuzhakov, VV; Kaminskaia, EV; Kovalenko, AL; Kvetnoi, IM; Popovich, IG; Popuchiev, VV; Proshin, SN; Zabezhinskii, MA; Zaripova, EA | 1 |
2 other study(ies) available for acridines and Rhabdomyosarcoma
| Article | Year |
|---|---|
In vitro assessment of novel transcription inhibitors and topoisomerase poisons in rhabdomyosarcoma cell lines.
Topics: Acridines; Aminoacridines; Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Nucleic Acid Synthesis Inhibitors; Phenazines; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Topoisomerase Inhibitors | 2009 |
[Effect of cycloferon on dissemination of Lewis lung carcinoma in mice and rhabdomyosarcoma ra-23 in rats].
Topics: Acridines; Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Division; Cyclophosphamide; Injections; Interferon Inducers; Mice; Mice, Inbred C57BL; Rats; Rhabdomyosarcoma | 1999 |